Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 253Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Cohance Lifesciences

02 1Emay Pharmaceuticals

03 1Octavius Pharma Pvt. Ltd

04 2Acino Pharma

05 2Apotex Inc

06 2Ascent Innovative Medicines

07 1Aspire Lifesciences Pvt Ltd

08 2Global Pharma Healthcare

09 2Kolmar Korea Co., Ltd.

10 2Laboratorio Eczane Pharma

11 4Murli Krishna Pharma

12 2Orchid Pharma

13 2PH HEALTH

14 4Pelcoat Formulations

15 2Smilax Laboratories Limited

16 2TWi Pharmaceuticals

17 11Takeda Pharmaceutical

18 2Viatris

19 4World Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEmay Pharmaceuticals is a GMP-certified API manufacturing company.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets

Dosage Strength : 20%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Emay Pharmaceuticals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets/Micro pellets for capsules

Dosage Strength : 17; 20; 22.5; 23%; %; %; %

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Delayed Release Pellet

Dosage Strength : 22.5%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

06

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Pellets

Dosage Strength : 17%W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Dexlansoprazole

Brand Name : Decpranzole Tablet

Dosage Form : Tablet

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

08

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

09

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

10

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

11

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

12

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT SOLUTAB

Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2016-01-26

Application Number : 208056

Regulatory Info : DISCN

Registration Country : USA

blank

13

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

14

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

15

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

16

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

17

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

18

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

19

PH HEALTH

Country
OTS 2025
Not Confirmed
arrow

PH HEALTH

Country
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2017-04-19

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank

20

PH HEALTH

Country
OTS 2025
Not Confirmed
arrow

PH HEALTH

Country
arrow
OTS 2025
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-06-16

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank